Gpharma SRL
Gpharma reported total assets of €1.66m at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Jun 2026).
The score of Gpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Gpharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Jun 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
Gpharma's financial analysis
- Solvency13.4%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Gpharma
Gpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1000.994.171
- VAT number
- BE1000994171
- Peppol
- Registered · 0208:1000994171 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Oct 2023
- Registered office
- 4122 Neupré
- Latest accounts
- 2025 · filed on 18 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Gpharma (SRL) has been based in Neupré since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 52,848 € and equity of 223,496 €; its revenue is not published. Its solvency stands at 13.4%, below the median of its sector (40.1%).
Companies similar to Gpharma
Companies in the same business, of comparable size and area, outside its group.
- AS Pharma Retail sale of pharmaceutical products Charleroi · balance sheet €1.62m
- Pharmakes Retail sale of pharmaceutical products Ypres · balance sheet €1.57m
- Cardoen Pharma Retail sale of pharmaceutical products Wingene · balance sheet €1.79m
- Duchi-Naert Retail sale of pharmaceutical products Harelbeke · balance sheet €1.52m
- Prieels Pharma Retail sale of pharmaceutical products Oud-Heverlee · balance sheet €1.29m
- Antares Invest Retail sale of pharmaceutical products Celles (lez-Tournai) · balance sheet €1.80m
- PiotFarma Retail sale of pharmaceutical products Tielt-Winge · balance sheet €1.79m
- Lunsiefar Retail sale of pharmaceutical products Overijse · balance sheet 839,787 €
Frequently asked questions about Gpharma
What is the revenue of Gpharma?
Gpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Gpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1000994171 for Gpharma, if the company is VAT-registered. Its company number (CBE) is 1000.994.171.
Where is the registered office of Gpharma?
According to the CBE register, the registered office of Gpharma is in 4122 Neupré.
What is the equity of Gpharma?
At the close of the 2025 financial year, the equity of Gpharma amounts to 223,496 €, a solvency of 13.4% of total assets.
Who manages Gpharma?
The register lists 1 active mandates at Gpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Gpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →